These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identifying Molecular Targets for New Drug Development for Chronic Obstructive Pulmonary Disease: What Does the Future Hold? Barnes PJ Semin Respir Crit Care Med; 2015 Aug; 36(4):508-22. PubMed ID: 26238638 [TBL] [Abstract][Full Text] [Related]
6. COPD: is there light at the end of the tunnel? Barnes PJ Curr Opin Pharmacol; 2004 Jun; 4(3):263-72. PubMed ID: 15140418 [TBL] [Abstract][Full Text] [Related]
7. New treatments for chronic obstructive pulmonary disease. Barnes PJ Ann Ist Super Sanita; 2003; 39(4):573-82. PubMed ID: 15098577 [TBL] [Abstract][Full Text] [Related]
8. Advances in chronic obstructive pulmonary disease. Barnes PJ Trans Med Soc Lond; 2002-2003; 119():41-51. PubMed ID: 17184031 [TBL] [Abstract][Full Text] [Related]
9. COPD: current therapeutic interventions and future approaches. Barnes PJ; Stockley RA Eur Respir J; 2005 Jun; 25(6):1084-106. PubMed ID: 15929966 [TBL] [Abstract][Full Text] [Related]
10. New treatments for COPD. Barnes PJ Nat Rev Drug Discov; 2002 Jun; 1(6):437-46. PubMed ID: 12119745 [TBL] [Abstract][Full Text] [Related]
11. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy. Onoue S; Misaka S; Kawabata Y; Yamada S Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334 [TBL] [Abstract][Full Text] [Related]
12. [New drug therapy of chronic obstructive pulmonary disease]. Kino H Nihon Rinsho; 2003 Dec; 61(12):2175-80. PubMed ID: 14674329 [TBL] [Abstract][Full Text] [Related]
13. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies. Fitzgerald MF; Fox JC Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532 [TBL] [Abstract][Full Text] [Related]
14. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566 [TBL] [Abstract][Full Text] [Related]
15. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Tamimi A; Serdarevic D; Hanania NA Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic options for chronic obstructive pulmonary disease: present and future. Sin DD Eur Rev Med Pharmacol Sci; 2004; 8(6):247-58. PubMed ID: 15745384 [TBL] [Abstract][Full Text] [Related]
17. Roflumilast for the treatment of chronic obstructive pulmonary disease. Antoniu SA Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716 [TBL] [Abstract][Full Text] [Related]
18. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. Ohar JA; Donohue JF Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301 [TBL] [Abstract][Full Text] [Related]
19. Future directions in the pharmacologic therapy of chronic obstructive pulmonary disease. Buhl R; Farmer SG Proc Am Thorac Soc; 2005; 2(1):83-93. PubMed ID: 16113474 [TBL] [Abstract][Full Text] [Related]
20. New treatments for COPD. Ngkelo A; Adcock IM Curr Opin Pharmacol; 2013 Jun; 13(3):362-9. PubMed ID: 23602653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]